The potent and selective inhibition of estrogen production by non-steroidal aromatase inhibitor, YM511
- 30 September 1995
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 54 (5-6), 265-271
- https://doi.org/10.1016/0960-0760(95)00136-n
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patientsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949ASteroids, 1987
- Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.Journal of Clinical Oncology, 1986
- The treatment of postmenopausal women with advanced breast cancer with buserelinCancer Chemotherapy and Pharmacology, 1985
- Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast CancerJournal of Clinical Endocrinology & Metabolism, 1982
- Aromatization of Androgens by Muscle and Adipose Tissue in Vivo*Journal of Clinical Endocrinology & Metabolism, 1978
- Studies on the mechanism of estrogen biosynthesis in the rat ovary–IThe Journal of Steroid Biochemistry and Molecular Biology, 1976